Prognostic implications of magee equation 3 and residual câncer burden in patients receiving neoadjuvant chemotherapy for hormone receptor-positive HER2-negative breast cãncer (2025)
- Authors:
- USP affiliated authors: BARACAT, EDMUND CHADA - FM ; FILASSI, JOSE ROBERTO - FM
- Unidade: FM
- DOI: 10.1016/j.modpat.2025.100733
- Subjects: NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA; QUIMIOTERAPIA ADJUVANTE
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: Modern Pathology
- ISSN: 0893-3952
- Volume/Número/Paginação/Ano: v. 38, n. 6, article ID 100733, 8p, 2025
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
VAZQUEZ, Thais Perez et al. Prognostic implications of magee equation 3 and residual câncer burden in patients receiving neoadjuvant chemotherapy for hormone receptor-positive HER2-negative breast cãncer. Modern Pathology, v. 38, n. 6, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/85124. Acesso em: 16 mar. 2026. -
APA
Vazquez, T. P., Goncalves, R., Cunha, J. P. G. da, Rivas, F. W. S., Aguiar, F. N., Baracat, E. C., & Filassi, J. R. (2025). Prognostic implications of magee equation 3 and residual câncer burden in patients receiving neoadjuvant chemotherapy for hormone receptor-positive HER2-negative breast cãncer. Modern Pathology, 38( 6). doi:10.1016/j.modpat.2025.100733 -
NLM
Vazquez TP, Goncalves R, Cunha JPG da, Rivas FWS, Aguiar FN, Baracat EC, Filassi JR. Prognostic implications of magee equation 3 and residual câncer burden in patients receiving neoadjuvant chemotherapy for hormone receptor-positive HER2-negative breast cãncer [Internet]. Modern Pathology. 2025 ; 38( 6):[citado 2026 mar. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/85124 -
Vancouver
Vazquez TP, Goncalves R, Cunha JPG da, Rivas FWS, Aguiar FN, Baracat EC, Filassi JR. Prognostic implications of magee equation 3 and residual câncer burden in patients receiving neoadjuvant chemotherapy for hormone receptor-positive HER2-negative breast cãncer [Internet]. Modern Pathology. 2025 ; 38( 6):[citado 2026 mar. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/85124 - Measurement of extracapsular extension in sentinel lymph node as a possible predictor of residual axillary disease in breast cancer
- Venous thromboembolism incidence in postoperative breast cancer patients
- Phyllodes tumors of the breast: a comprehensive review of diagnosis, treatment, and follow-up
- Mapping delays in breast câncer care during COVID-19: lessons from the Brazilian Public Health System (SUS). [Editorial]
- Identificacao, localizacao e valor prognostico da beta-2-microglobulina no cancer do colo uterino
- Análise citomorfológica, proteômica e lipidômica do fluido papilar da mama
- Validation of the Residual Cancer Burden Index as a prognostic tool in women with locally advanced breast cancer treated with neoadjuvant chemotherapy
- Genicologia endócrina de consultório
- Effects of preoperative magnetic resonance image on survival rates and surgical planning in breast cancer conservative surgery: randomized controlled trial (BREAST-MRI trial)
- Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
